| Value | ₹35.00 Cr |
|---|
BSE filing, NSE: MONEYBOXX. Summary written from the filing by ALFA Finder's alert engine.
Moneyboxx Finance Ltd: key numbers
- Share price
- ₹44.13
- Market cap
- ₹308.1 Cr
- Revenue (annual)
- ₹231.8 Cr
- Net profit (annual)
- ₹1.34 Cr
- P/E (TTM)
- 236.1×Sector 19.8×
- Promoter holding
- 46.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Moneyboxx Finance Ltd
All →Moneyboxx Finance Debt & Borrowing: ₹0.21 Cr
Moneyboxx Finance paid Rs.0.21 Crore interest on its Rs.25 Crore secured NCDs on October 26, 2026. The payment was made before the October 28 due date.
- Value
- ₹0.21 Cr
Moneyboxx Finance Debt & Borrowing: ₹1.18 Cr
Moneyboxx Finance paid Rs. 1.18 Crore interest on three listed secured NCD series on 22 October 2026. Payments were made ahead of due dates.
- Value
- ₹1.18 Cr
Moneyboxx Finance Debt & Borrowing: ₹0.44 Cr
Moneyboxx Finance Limited has successfully paid interest of Rs.0.44 Crore on its senior secured non-convertible debentures for the period ending October 2026.
- Value
- ₹0.44 Cr
Moneyboxx Finance Debt & Borrowing: ₹0.34 Cr
Moneyboxx Finance paid ₹0.34 Crore in monthly interest on its senior secured NCDs. The payment was completed on October 14, 2026.
- Value
- ₹0.34 Cr
Moneyboxx Finance Debt & Borrowing: ₹0.07 Cr
Moneyboxx Finance Ltd successfully paid Rs.0.07 Crore interest on its non-convertible debentures for the period ending October 2026.
- Value
- ₹0.07 Cr
Moneyboxx Finance Other Announcement
Moneyboxx Finance Limited has submitted the updated contact details of its Compliance Officer and Registrar and Share Transfer Agent (RTA).
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.